Revenue Growth

Zacks Small-Cap Research initiated coverage on Cosmos Health with a $4.50 price target. They highlight the company’s diversified, vertically integrated model, anticipating strong revenue growth driven by high-margin pharmaceuticals, nutraceuticals, telehealth, and AI R&D. The valuation is based on a five-year DCF analysis, factoring in U.S. market expansion, a $300 million financing facility, and digital asset strategy. Zacks also noted positive recent financial performance.

Teva Pharmaceutical Industries has received upgraded credit ratings and a positive outlook from S&P and Moody’s. These actions reflect the company’s successful “Pivot to Growth” strategy, evidenced by consistent deleveraging and a return to revenue growth. Strong performance in branded medicines and upcoming biosimilar launches are key drivers, offsetting generics headwinds. This signifies Teva’s progress toward financial health and potentially investment-grade status.

Telescope Innovations reported a 31.8% revenue surge to CAD $5.8 million in FY2025, alongside increased R&D spending. Key developments include progress on a Pfizer Self-Driving Lab project, record sales for DirectInject-LC with European and Asian market entries, and initial shipments of battery-grade lithium sulfide produced via a proprietary method. The company is transitioning from development to commercialization, aiming to capitalize on demand for intelligent, automated chemistry solutions.

words.CSPi (NASDAQ:CSPI) will announce its fiscal 2025 fourth‑quarter and full‑year results before the market opens on Tuesday, December 16, 2025. President and CEO Victor Dellovo and CFO Gary W. Levine will host a conference call at 10:00 a.m. ET, with a live webcast on the company’s website and a replay available for a year. Investors can join by phone using access code 977008. In Q3 FY2025, CSPi posted $15.45 million in revenue, a $1.22 million operating loss, $44.27 million nine‑month revenue, $0.10 million net income and $26.31 million cash on hand.

.Broadcom beat Q4 expectations, reporting $1.95 EPS and $18.02 bn revenue, and forecast FY‑Q1 revenue of about $19.1 bn, a 28% YoY rise driven by AI demand. AI‑related chip sales doubled to $8.2 bn, boosting net income 97% to $8.51 bn. The company added a fifth custom‑AI customer, with orders totaling $11 bn and a $1 bn commitment for 2026, bringing its AI backlog to $73 bn. Broadcom’s XPU strategy aims to combine GPU throughput with ASIC efficiency, positioning it as a full‑stack AI infrastructure provider amid intense competition from Nvidia and others.

Rubrik’s shares jumped 22% after a stellar FY Q3, with revenue up 48% YoY to $350 million and adjusted earnings of $0.10 per share, surpassing expectations. The company lifted its full‑year revenue forecast to $1.28‑$1.282 billion and highlighted growth driven by AI‑focused cyber‑resilience solutions. Net loss narrowed to $63.8 million, and new contracts with a major Asian bank and a Fortune 250 firm underscore market traction. With the data‑protection market projected to exceed $30 billion by 2027, Rubrik’s API‑first, zero‑trust platform positions it for high‑velocity growth despite competitive and macro risks.

CrowdStrike posted FY 2026 Q3 results that topped forecasts, with revenue climbing 22% YoY to $1.23 billion and adjusted EPS reaching $0.96. The company recorded its highest operating cash flow, free cash flow and operating income, while net new ARR hit $265 million, lifting year‑end ARR to $4.92 billion—30% of which came from the on‑demand Falcon Flex tier. CEO George Kurtz warned AI is expanding both attack surfaces and defense needs, prompting a raised FY revenue outlook of $4.796‑$4.866 billion and EPS of $3.70‑$3.72. Analysts maintain a “Buy” rating with a $550 price target.

.MongoDB’s stock jumped over 25% after the company posted Q3 results that beat estimates, reporting $1.32 earnings per share on $628 million revenue (19% YoY growth). Its Atlas cloud database contributed about 75% of revenue, expanding 30% to more than 60,800 customers. New CEO CJ Desai highlighted AI‑driven demand and raised full‑year revenue guidance to $2.434‑$2.439 billion. Analysts lifted price targets, noting strong consumption, AI tailwinds, and a favorable rate environment. Despite rising competition, MongoDB’s multi‑cloud, developer‑centric platform underpins its 40% YTD stock gain.

words.SATO Technologies reported Q3 2025 revenue of $3.34 million, up 28% YoY, and a gross profit of $381,566 versus a loss a year earlier. Net loss improved to $(284,424). Bitcoin mining fell 32% to 21 BTC, while compute‑power profit rose to $921,602 and adjusted EBITDA to $333,505. Digital assets totaled $1.46 million (9 BTC) and cash stood at $640,621. Center One achieved >99% uptime. To preserve liquidity, the company secured a three‑month payment deferral, deferred executive pay, cut contractors, considered equipment sales, and temporarily down‑clocked ~40% of its mining fleet. It is launching an AI‑compute shift with an initial ~200‑GPU rollout, scalable to over 2,000 units; a results presentation will be posted on Dec 2, 2025.

.In November, Palantir’s stock fell 16%—its sharpest drop since August 2023—after investors questioned its lofty AI‑related valuation despite a $1 billion‑revenue quarter and beating earnings expectations. Analysts labeled the price “extreme,” and Michael Burry’s short position sparked CEO Alex Karp’s accusations of market manipulation. The firm secured multi‑year deals with PwC and FTAI Aviation, yet trades at ~233× forward earnings versus peers’ 30‑40×. Palantir projects 53% FY 2025 revenue growth, but faces concentration, margin, competition, and valuation risks.